Home -> Law Blog Directory -> Patent Law Blogs -> Patent Baristas
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent BaristasUpcoming Patent Events: Pharma/Biotech IP Due Diligence
By Stephen Albainy-Jenei
Whether you are a company conducting diligence or a target being examined, you need to ensure the value of the IP with a thorough and effective IP due diligence review.
In this light, the American Conference Institute?s 6th National Conference on Pharma/Biotech IP Due Diligence will be held at the Marriott East Side, New York, NY, on Wednesday, January 28, 2009 to Thursday, January 29, 2009.
IP due diligence is now a central concern and struggle for companies in life science-related industries, due to the substantial growth of mergers and acquisitions, spin-outs, and divestitures, as well as the evolving role of licensing and collaborative arrangements. If the due diligence is not properly conducted, you run the risk of loss of reputation, loss of profits, or even ruin.
Furthermore, since the intellectual property at issue can make or break a deal, it is imperative that you are aware of all of the current changes to patent practices. Proposed legislation, recent case law and proposed USPTO Rules complicate the patent landscape even further.
This conference is billed as the ONLY proven event where an experienced faculty of leading IP practitioners and in-house patent and IP counsel will not only give you the most up-to-date information about a constantly evolving patent landscape, but will show you how to incorporate these changes into your diligence review to accurately analyze the value of the IP.
You will also learn best practices from representatives of leading companies who have ?been there? and managed successful and cost-effective IP diligence review, including practical advice and the tools you need to develop flexible checklists, structure the review based on the type of deal, evaluate the patent portfolio, prepare for the review and much more.
There is also and add-on Master Class: Drafting a Comprehensive Due Diligence Report - One Size Does Not Fit All
More information and registration is at the ACI website.
Patent Baristas is a Media Partner for this event.
Full post as published by Patent Baristas on October 15, 2008 (boomark / email).
NCAA and Ticketmaster
alleging they have a monopoly on college sports events and charge non-refundable fees to enter a lottery for the rights to purchase tickets to the sporting events.
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Medical Records
To Stay out of Pharma's Hands
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.

C5 Pharma/Biotech IP Due Diligence Conference
ACI "Pharma/Biotech IP Due Diligence" Conference, New York, January 30-31
ACI Pharma/Biotech IP Due Diligence Conference
Biotech/Pharma Lobbying Scoreboard - Part II
Biotech/Pharma Lobbying Scoreboard - Second Quarter Update
Biotech and Pharma Opposition to Senate Patent Reform Bill








